A Retrospective Nationwide Non-Interventional Study of an Aqueous Sublingual Immunotherapy Formulation Administered with a 200-µL Dosing Pump.

Background: Convenient dosing is a key component of treatment adherence and thus efficacy and safety. Aqueous sublingual immunotherapy (SLIT) formulations can be administered with a dosing pump that delivers 200 µL of volume per actuation.

Objective: The objective of this study was to describe the use of Staloral 300 Rapid in its new dosing pump presentation and to evaluate the safety and satisfaction from both the patient and doctor.